NCT03219047 2023-07-27Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell LymphomaM.D. Anderson Cancer CenterPhase EARLY_PHASE1 Completed1 enrolled